mRNA |
GSK429286A |
GDSC1000 |
pan-cancer |
AAC |
-0.0059 |
0.9 |
mRNA |
momelotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0057 |
0.9 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0057 |
0.9 |
mRNA |
GW-405833 |
CTRPv2 |
pan-cancer |
AAC |
-0.0054 |
0.9 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.005 |
0.9 |
mRNA |
Vandetanib |
FIMM |
pan-cancer |
AAC |
-0.027 |
0.9 |
mRNA |
NVP-ADW742 |
CTRPv2 |
pan-cancer |
AAC |
-0.005 |
0.9 |
mRNA |
BRD-K64610608 |
CTRPv2 |
pan-cancer |
AAC |
-0.0056 |
0.9 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.9 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0049 |
0.9 |